- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/08 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
Patent holdings for IPC class C07D 211/08
Total number of patents in this class: 103
10-year publication summary
|
4
|
5
|
5
|
6
|
4
|
3
|
2
|
3
|
6
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mebias Discovery, Inc. | 8 |
6 |
| Bristol-myers Squibb Company | 4812 |
5 |
| The Trustees of the University of Pennsylvania | 4403 |
4 |
| Owen-barry Pharmaceuticals Inc. | 8 |
3 |
| The Regents of the University of California | 20534 |
2 |
| Merck Sharp & Dohme Corp. | 2184 |
2 |
| Boehringer Ingelheim International GmbH | 4529 |
2 |
| Allergan, Inc. | 2214 |
2 |
| Vertex Pharmaceuticals Incorporated | 1600 |
2 |
| ELC Management LLC | 1148 |
2 |
| Flexus Biosciences, Inc. | 13 |
2 |
| Global Blood Therapeutics, Inc. | 177 |
2 |
| Shire Human Genetic Therapies, Inc. | 190 |
2 |
| The Trustees of Princeton University | 1245 |
2 |
| Xention Limited | 8 |
2 |
| Seoul National University R&db Foundation | 3996 |
2 |
| F. Hoffmann-La Roche AG | 7835 |
1 |
| 3m Innovative Properties Company | 17512 |
1 |
| Genentech, Inc. | 4065 |
1 |
| Syngenta Crop Protection, Inc. | 14 |
1 |
| Other owners | 57 |